Canada markets open in 4 hours 16 minutes

LexaGene Holdings Inc. (LXG.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.76000.0000 (0.00%)
At close: 3:59PM EDT
Full screen
Previous Close0.7600
Open0.7700
Bid0.7500 x 0
Ask0.7600 x 0
Day's Range0.7500 - 0.7700
52 Week Range0.4800 - 1.5400
Volume153,355
Avg. Volume165,680
Market Cap86.915M
Beta (5Y Monthly)2.05
PE Ratio (TTM)N/A
EPS (TTM)-0.1160
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • LexaGene Closes Sale to Alpine Veterinary Hospital
    GlobeNewswire

    LexaGene Closes Sale to Alpine Veterinary Hospital

    LexaGene to Present at Multiple ConferencesBEVERLY, Mass., June 14, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG), a molecular diagnostics company, announced the Company has sold another MiQLab™ System and the CEO will present at multiple conferences. LexaGene CEO and Founder, Dr. Jack Regan, states, “Following up on last weeks’ sales news, I’m pleased to report we have sold another MiQLab System. We will be shipping this purchased system to Alpine Veterinary Hospi

  • LexaGene detects a slow-growing bacterium at least 36-times faster than conventional methods with the potential to increase vaccine safety and supply
    GlobeNewswire

    LexaGene detects a slow-growing bacterium at least 36-times faster than conventional methods with the potential to increase vaccine safety and supply

    MiQLab detects 100% of C. acnes samples 36-times faster than a culture started from ideal laboratory conditions (in 2 hours versus 3 days)MiQLab can be as much as 168-times faster than a culture started from a bioreactor sample (2 hours versus 14 days)Adopting MiQLab could lead to significant cost savings for biopharmaceutical manufacturers BEVERLY, Mass., June 10, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) a molecular diagnostics company that develops fully aut

  • LexaGene Sells a MiQLab System to Denver Animal Emergency
    GlobeNewswire

    LexaGene Sells a MiQLab System to Denver Animal Emergency

    BEVERLY, Mass., June 07, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, is pleased to announce Denver Animal Emergency has provided LexaGene a purchase order for a MiQLab System™. Dr. Andrew Pierce, Owner and Medical Director of Denver Animal Emergency in North Carolina, states, “We have been using LexaGene’s MiQLab for several months as part of their Ear